News – Page 524 – Endpoints News

FDA approves oral formulation of old ALS drug, giving patients new treatment option in sorely needed field

3 years ago

Working to right the ship, BridgeBio's Neil Kumar adds a $110M deal right on top of his cash haul from Bristol Myers

3 years ago

Hello, I must be going: Jorge Gomez is Moderna CFO for only a day; As setbacks mount, Inovio’s Joseph Kim chooses ...

3 years ago

Arkansas accuses Eli Lilly, Novo Nordisk, and Sanofi of colluding to drive up insulin prices

3 years ago

CSL's $11.7B buyout hits antitrust delay — is it a sign of what's to come?

3 years ago

Teva, Allergan open to settling 3500+ lawsuits for more than $5B as negotiations continue — report

3 years ago

Global license program to receive Covid-19 support from the NIH

3 years ago

Boy bands and psoriatic arthritis? NSYNC’s Lance Bass creates new dance for Amgen about early signs

3 years ago

PCI further expands into New England with fill-finish upgrade in New Hampshire

3 years ago

Eylea keeps its lead in the retinal space as physicians remain hesitant on Roche's Susvimo — report

3 years ago

‘Say no more’ to yeast infections: Scynexis rolls out new Brexafemme marketing — and rallying cry

3 years ago

Indian manufacturer hit with Form 483 — again

3 years ago

Q&A: Through robotics, Fred Parietti and team look to fix cell therapy's future

3 years ago

Stanford study suggests brain fluid transfer from young to old mice can improve memory

3 years ago

Caribou aces its first round of human data in search of an off-the-shelf CAR-T breakthrough

3 years ago

Rinvoq passes PhIII maintenance study for Crohn's disease, potentially setting the stage for label expansion

3 years ago

Bristol Myers builds the case for psoriasis hopeful as it waits in regulatory limbo

3 years ago

Ahead of second FDA chance, CorMedix winds down European business

3 years ago

Is Paxlovid, the Covid pill, reaching those who most need it? The government won’t say

3 years ago

A week after disclosing layoffs, BridgeBio nets a $90M upfront cancer R&D pact with Bristol Myers

3 years ago

Sana's Terry Fry leads new $200M cell and gene therapy institute at University of Colorado

3 years ago

Cullinan Oncology goes full circle, scoring $275M for sharing the load on EGFR inhibitor with original developer

3 years ago

Arrest report, court docs outline multiple spouse abuse allegations against Seagen founder Clay Siegall

3 years ago

Merck offers empathy to pandemic-battered parents in revamped HPV vaccine awareness campaign

3 years ago

First page Previous page 521 522 523524525 526 527 Next page Last page